AstraZeneca will acquire all outstanding equity of EsoBiotec for a total consideration of up to $1,000m, on a cash and debt free basis. This will include an initial payment of $425m on deal closing, ...

Shortly after Intel announced his hiring Wednesday afternoon, new CEO Lip-Bu Tan greeted the chipmaker’s employees on a ...

When Pat Gelsinger tool the helm at Intel in 2021, the company was already in rough shape. Here's what Intel's new CEO is ...

Mr. Tan retains an active role in many small and midsize tech hardware companies. He was named executive chairman last May of ...

My name is Abby, and I will be your conference operator today. At this time, I would like to welcome everyone to the Oracle ...

"This is a historic moment for 4DMT as we become a Phase 3 company following our initiation of the 4FRONT-1 clinical trial,” said David Kirn, M.D., Co-founder and Chief Executive Officer of 4DMT.